Table 2 The clinical characteristics and CA 19 − 9 level of the HbA1c < 9% group and control group
Variables | The HbA1c < 9% group (n = 199) | Non-diabetes controls (n = 200) | p value |
|---|---|---|---|
CA 19−9 levels (U/ml) | 14.8 ± 9.6 | 13.6 ± 8.9 | 0.128 |
Proportion of objects with abnormal CA 19−9 | 6/199 (3.0%) | 5/200 (2.5%) | 0.753 |
Age (years) | 59.9 ± 11.6 | 57.5 ± 14.2 | 0.253 |
Female sex | 62 (31.2%) | 64 (32.0%) | 0.856 |
BMI (kg/m2) | 25.2 ± 3.2 | 25.4 ± 3.8 | 0.422 |
HbA1c (%) | 7.26 ± 0.98 | 4.8 ± 1.02 | < 0.001* |
Systolic blood pressure (mmHg) | 133.4 ± 19.7 | 130.1 ± 15.6 | 0.105 |
Diastolic blood pressure (mmHg) | 79.9 ± 11.5 | 76.8 ± 11.9 | 0.182 |
Uric acid (µmol/l) | 330.1 ± 93.8 | 326.5 ± 91.2 | 0.243 |
Total cholesterol (mmol/l) | 4.59 ± 1.24 | 4.68 ± 1.39 | 0.642 |
Triglycerides (mmol/l) | 1.84 ± 1.64 | 1.93 ± 1.74 | 0.506 |
Creatinine (µmol/l) | 72.0 ± 27.6 | 67.6 ± 15.3 | 0.081 |
ALT (U/L) | 25.2 ± 15.0 | 26.9 ± 18.2 | 0.257 |